National Cancer Institute; Notice of Closed Meetings, 76668-76669 [E8-29822]

Download as PDF 76668 Federal Register / Vol. 73, No. 243 / Wednesday, December 17, 2008 / Notices [FR Doc. E8–29952 Filed 12–16–08; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; Comment Request; The Effectiveness of the NIH Curriculum Supplements Programs and Career Resources Summary: Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of the Director, Office of Science Policy, Office of Science Education, National Institutes of Health has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on September 23, 2008 (Volume 73, Number 185, page 54840) and allowed 60-days for public comment. One comment was received. The purpose of this notice is to allow 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB number. Proposed Collection Title: The Effectiveness of the NIH Curriculum Supplements Programs and Career Resources. Information Collection Request: Reinstatement. Need and Use of Information Collection: The survey will attempt to assess customer demographics and their satisfaction with the NIH curriculum supplements in presenting science in a more engaging and interactive way. The supplements help K–12 educators teach science by featuring the latest NIH research and utilized research-based instructional methods. A typical supplement contains two weeks of student activities on the science behind a health topic, such as cancer, sleep or Type of respondent: Survey title Number of respondents obesity. Web-based simulations, animations and experiments enhance the ‘‘pencil and paper’’ activities. In addition to developing and distributing the supplements, OSE conducts professional workshops to help teachers successfully implement these lessons with their students. Since January 2000, over 6,000 teachers have attended an OSE workshop. OSE also develops a series of videos, Women Are Scientists, that aim to excite middle school students on careers in the health sciences. Assessing the effectiveness of the NIH curriculum supplements, teacher workshops, and career resources is critical to determining if OSE is successfully fulfilling its mission. OSE has the database infrastructure in place to easily collect data from supplement and career video requesters and workshop attendees. At present, we do not have clearance to contact our customers to determine how NIH resources are meeting their educational needs. Burden Table Frequency of response Average time per response (hours) Hour burden per year (hours) Supplement requestor ..................................................................................... Career video requestor .................................................................................... Workshop Teacher: initial survey .................................................................... Workshop Teacher: in-depth survey ................................................................ 16,000 1,500 2,000 200 1 1 1 1 0.17 0.17 0.17 0.5 910 85 117 34 Totals ........................................................................................................ 19,700 a a 1,146 pwalker on PROD1PC71 with NOTICES a N/A. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) ways to enhance the quality, utility, and clarity of the information to be collected; and (3) ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by VerDate Aug<31>2005 18:58 Dec 16, 2008 Jkt 217001 fax to 202–395–6974, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. David Vannier, National Institutes of Health, Office of Science Education, 6100 Executive Boulevard, Suite 3E01, Bethesda, MD 20892, or call 301–496– 8741, or e-mail your request including your address to vannierd@od.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. Dated: December 4, 2008. David Vannier, Office of Science Education, National Institutes of Health. [FR Doc. E8–29815 Filed 12–16–08; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2); notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\17DEN1.SGM 17DEN1 Federal Register / Vol. 73, No. 243 / Wednesday, December 17, 2008 / Notices pwalker on PROD1PC71 with NOTICES Name of Committee: National Cancer Institute Special Emphasis Panel; Clinical Studies P01. Date: February 18, 2009. Time: 8 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Majed M. Hamawy, PhD, Scientific Review Officer, Research Programs Review Branch, Division Of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8135, Bethesda, MD 20852, 301–594–5659, mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Quantitative Imaging for Evaluation of Responses to Cancer Therapies. Date: March 2–3, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC North Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877. Contact Person: Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892–8329, 301–496–7576, bielatk@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Cancer Prevention Research. Date: March 16–17, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Luxury Hotel and Suites, 2033 M Street, NW., Washington, DC 20036. Contact Person: Irina Gordienko, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 7073, Bethesda, MD 20892, 301–594–1566, gordienkoiv@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–29822 Filed 12–16–08; 8:45 am] BILLING CODE 4140–01–P VerDate Aug<31>2005 18:58 Dec 16, 2008 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee I—Career Development. Date: February 10–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Washington DC, 1515 Rhode Island Ave, Washington, DC 20005. Contact Person: Sonya Roberson, PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8109, Bethesda, MD 20892, 301–594–1182, robersos@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Molecular Profiles in Tumors. Date: February 19, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892–8329, 301–496–7576, bielatk@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Innovative Strategies to Protect Radiosensitive Organs. Date: February 26, 2009. Time: 9:30 a.m. to 1:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Marvin L Salin, PhD, Scientific Review Officer, Special Review PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 76669 and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, 301–496–0694, msalin@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Innovative Technologies for Molecular Analysis of Cancer (R21). Date: March 4–5, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Adriana Stoica, PhD, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd, Ste 703, Room 7072, Bethesda, MD 20892–8329, 301–594–1408, Stoicaa2@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Platforms for Improved Diagnosis of Cancer. Date: March 16–17, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Hilton Washington DC North/ Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877. Contact Person: Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892–8329, 301–496–7576, bielatk@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–29824 Filed 12–16–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the President’s Cancer Panel. The meeting will be open to the public as indicated below, with E:\FR\FM\17DEN1.SGM 17DEN1

Agencies

[Federal Register Volume 73, Number 243 (Wednesday, December 17, 2008)]
[Notices]
[Pages 76668-76669]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29822]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2); notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 76669]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Studies P01.
    Date: February 18, 2009.
    Time: 8 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Majed M. Hamawy, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division Of Extramural Activities, 
National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8135, 
Bethesda, MD 20852, 301-594-5659, mh101v@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Quantitative Imaging for Evaluation of Responses to Cancer 
Therapies.
    Date: March 2-3, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC North Gaithersburg, 620 Perry 
Parkway, Gaithersburg, MD 20877.
    Contact Person: Kenneth L. Bielat, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7147, Bethesda, MD 20892-8329, 301-496-7576, 
bielatk@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Cancer Prevention Research.
    Date: March 16-17, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Luxury Hotel and Suites, 2033 M Street, NW., 
Washington, DC 20036.
    Contact Person: Irina Gordienko, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 7073, Bethesda, MD 20892, 301-594-1566, 
gordienkoiv@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-29822 Filed 12-16-08; 8:45 am]
BILLING CODE 4140-01-P